167 related articles for article (PubMed ID: 9028697)
1. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report.
Lahtela JT; Knip M; Paul R; Antonen J; Salmi J
Diabetes Care; 1997 Jan; 20(1):71-3. PubMed ID: 9028697
[TBL] [Abstract][Full Text] [Related]
2. Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
Schmauss S; König A; Landgraf R
Diabet Med; 1998 Mar; 15(3):247-9. PubMed ID: 9545126
[TBL] [Abstract][Full Text] [Related]
3. Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period.
Jacobs MA; Keulen ET; Kanc K; Casteleijn S; Scheffer P; Devillé W; Heine RJ
Diabetes Care; 1997 Aug; 20(8):1279-86. PubMed ID: 9250454
[TBL] [Abstract][Full Text] [Related]
4. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB
Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684
[TBL] [Abstract][Full Text] [Related]
5. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
Fineberg NS; Fineberg SE; Anderson JH; Birkett MA; Gibson RG; Hufferd S
Diabetes; 1996 Dec; 45(12):1750-4. PubMed ID: 8922361
[TBL] [Abstract][Full Text] [Related]
6. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
Renner R; Pfützner A; Trautmann M; Harzer O; Sauter K; Landgraf R
Diabetes Care; 1999 May; 22(5):784-8. PubMed ID: 10332682
[TBL] [Abstract][Full Text] [Related]
7. Impact of insulin lispro on HbA1c values in insulin pump users.
Garg SK; Anderson JH; Gerard LA; Mackenzie TA; Gottlieb PA; Jennings MK; Chase HP
Diabetes Obes Metab; 2000 Oct; 2(5):307-11. PubMed ID: 11225746
[TBL] [Abstract][Full Text] [Related]
8. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated insulin resistance treated by cessation of insulin administration.
Hara K; Tobe K; Uchigata Y; Nakazono M; Yasuda K; Terauchi Y; Iwamoto Y; Akanuma Y; Kimura S; Kadowaki T
Intern Med; 2000 Feb; 39(2):143-5. PubMed ID: 10732832
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
Comulada AL; Renard E; Nakano M; Rais N; Mao X; Webb DM; Milicevic Z
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S17-25. PubMed ID: 19772445
[TBL] [Abstract][Full Text] [Related]
11. [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
Guerci B; Jeandidier N; Lassmann-Vague V; Renard E; Hanaire-Broutin H
Diabetes Metab; 2000 Dec; 26(6):513-9. PubMed ID: 11173725
[TBL] [Abstract][Full Text] [Related]
12. Severe insulin resistance secondary to insulin antibodies: successful treatment with the immunosuppressant MMF.
Segal T; Webb E; Viner R; Pusey C; Wild G; Allgrove J
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):250-4. PubMed ID: 18547238
[TBL] [Abstract][Full Text] [Related]
13. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
[TBL] [Abstract][Full Text] [Related]
14. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
[TBL] [Abstract][Full Text] [Related]
15. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.
Heller SR; Amiel SA; Mansell P
Diabetes Care; 1999 Oct; 22(10):1607-11. PubMed ID: 10526722
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.
Weinzimer SA; Ternand C; Howard C; Chang CT; Becker DJ; Laffel LM;
Diabetes Care; 2008 Feb; 31(2):210-5. PubMed ID: 17989308
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.
García L; Lamas C; Tuset MJ; Alonso M; Barrio R
Diabetes Nutr Metab; 2002 Feb; 15(1):7-13. PubMed ID: 11942742
[TBL] [Abstract][Full Text] [Related]
18. Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.
Bode B; Weinstein R; Bell D; McGill J; Nadeau D; Raskin P; Davidson J; Henry R; Huang WC; Reinhardt RR
Diabetes Care; 2002 Mar; 25(3):439-44. PubMed ID: 11874927
[TBL] [Abstract][Full Text] [Related]
19. Severe insulin resistance treated with insulin lispro.
Gill G; Williams G
Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571
[No Abstract] [Full Text] [Related]
20. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
Lalli C; Ciofetta M; Del Sindaco P; Torlone E; Pampanelli S; Compagnucci P; Cartechini MG; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1999 Mar; 22(3):468-77. PubMed ID: 10097931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
